Cellules compétentes Rosetta gami B

Non disponible en dehors du Royaume-Uni et de l'Irlande

Components

0.4 ml1 mlComponentr> 2 × 0.2 ml5 × 0.2 mlRosetta-gami B Competent Cellsr> 2 × 2 ml4 × 2 mlSOC Mediumr> 10 µl10 µlTest Plasmid

General description

Rosetta-gami B strains combine the key features of BL21, Origami, and Rosetta to enhance both the expression of eukaryotic proteins and the formation of target protein disulfide bonds.

Genotype: F^–ompT hsdS_B (r_B^– m_B^–) gal dcm lacY1 ahpC gor522::Tn10 trxB pRARE (Cam^R, Kan^R, Tet^R)r>r>r>This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges us to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.

Rosetta-gami B strains combine the key features of BL21 (and its Tuner™ derivative), Origami, and Rosetta to enhance both the expression of eukaryotic proteins and the formation of target protein disulfide bonds in the bacterial cytoplasm. These strains are compatible with ampicillin- or spectinomycin-resistant vectors.

Legal Information

NOVAGEN is a registered trademark of Merck KGaA, Darmstadt, Germany

Packaging

1 ml in Glass bottle

0.4 ml in Plastic ampoule

Warning

Toxicity: Multiple Toxicity Values, refer to MSDS (O)